Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.630
-0.020 (-1.21%)
At close: Apr 28, 2026, 4:00 PM EDT
1.570
-0.060 (-3.68%)
After-hours: Apr 28, 2026, 7:48 PM EDT
Co-Diagnostics Stock Forecast
CODX's stock price has decreased by -84.48% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Co-Diagnostics stock has a target of 90, which predicts an increase of 5,421.47% from the current stock price of 1.63.
Analyst Consensus: Buy
* Price targets were last updated on Oct 28, 2025.
Analyst Ratings
The average analyst rating for Co-Diagnostics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 23, 2026 |
| Maxim Group | Maxim Group | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +2,660.74% | Nov 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 24, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $90 | Strong Buy | Maintains | $90 | +5,421.47% | Oct 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $90 | Strong Buy | Maintains | $90 | +5,421.47% | Oct 16, 2025 |
Financial Forecast
Revenue This Year
587.52K
from 622.49K
Decreased by -5.62%
Revenue Next Year
17.53M
from 587.52K
Increased by 2,883.73%
EPS This Year
-12.39
from -35.25
EPS Next Year
-12.24
from -12.39
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 630,000 | 18.0M | ||||||
| Avg | 587,520 | 17.5M | ||||||
| Low | 540,960 | 16.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.2% | 2,971.4% | ||||||
| Avg | -5.6% | 2,883.7% | ||||||
| Low | -13.1% | 2,766.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -11.34 | -12.60 | ||||||
| Avg | -12.39 | -12.24 | ||||||
| Low | -13.23 | -11.76 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.